ACET Q1 2021 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$4M-299.1% YoY

Gross Profit

-$4M100.0% margin

Operating Income

-$21M536.4% margin

Net Income

-$21M535.5% margin

EPS (Diluted)

$-13.12

QoQ Revenue Growth

-173.6%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$16M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$282M

Total Liabilities

$46M

Stockholders' Equity

$236M

Cash & Equivalents

$222M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$4M	$2M	-299.1%
Gross Profit	-$4M	$2M	-299.1%
Operating Income	-$21M	-$8M	-182.6%
Net Income	-$21M	-$4M	-375.2%